Management of Recurrent PSVT Episodes Over Two Weeks
This patient requires urgent cardiology referral for catheter ablation, which is the definitive first-line therapy for recurrent symptomatic PSVT, with single-procedure success rates of 94-98% 1.
Immediate Assessment and Acute Management
Since the patient's episodes have self-terminated, the immediate priority is:
- Document the arrhythmia: If not already captured on ECG, provide ambulatory monitoring (Holter or event monitor) to confirm PSVT diagnosis during the next episode 1
- Assess for tachycardia-mediated cardiomyopathy: Two weeks of recurrent episodes at 180 bpm warrants echocardiography to evaluate left ventricular function, as untreated PSVT can cause cardiomyopathy in approximately 1% of patients 1
For Future Acute Episodes (Patient Education)
Teach the patient this stepwise approach for self-management when episodes occur:
- Modified Valsalva maneuver (43% effective): Bear down against a closed glottis for 10-30 seconds with at least 30-40 mmHg pressure 2
- Ice-cold wet towel to face (diving reflex) 2
- Seek emergency care if symptoms persist beyond 15-20 minutes or if hemodynamically unstable
If the patient presents to ED during an episode:
- Adenosine 12 mg IV is more effective than 6 mg as initial dose (54.2% vs 40.6% conversion rate, p=0.03) 3, with overall 91% effectiveness 1
- At heart rate 180 bpm, adenosine is highly effective (>75% success for rates >166 bpm) 4
- Alternative: IV diltiazem or verapamil (80-98% effective) if adenosine contraindicated 2
Definitive Long-Term Management
Catheter ablation should be offered as first-line definitive therapy 1. The evidence strongly supports this approach:
- Success rates: 94.3-98.5% from meta-analyses 1
- Safe and highly effective for preventing recurrence 1
- Superior to pharmacotherapy for long-term management
- Guidelines recommend ablation as first-line therapy to prevent recurrence 1
If Patient Declines or Cannot Undergo Ablation
Long-term pharmacotherapy is less effective but can be considered 1:
- Beta-blockers (e.g., metoprolol, atenolol)
- Calcium channel blockers (diltiazem or verapamil)
- Antiarrhythmic agents as second-line
Important caveat: The evidence for long-term pharmacotherapy effectiveness is limited 1, and these medications only suppress episodes rather than cure the underlying re-entry circuit.
Critical Pitfalls to Avoid
- Do not delay cardiology referral: Two weeks of recurrent episodes represents significant symptom burden and risk for complications
- Avoid verapamil/diltiazem if wide-complex tachycardia or pre-excited AF: Can cause hemodynamic collapse 2
- Screen for cardiomyopathy: Prolonged tachycardia can cause reversible LV dysfunction
- Do not rely solely on vagal maneuvers: Only 31% success rate in real-world practice 3
Risk Stratification
This patient's presentation (recurrent episodes over 2 weeks, HR 180 bpm) indicates:
- High symptom burden requiring definitive therapy
- Increased risk of quality of life impairment 1
- Potential for tachycardia-mediated cardiomyopathy if left untreated 1
The algorithmic approach is: Document arrhythmia → Assess cardiac function → Refer for catheter ablation → Bridge with acute management strategies and consider temporary pharmacotherapy only if ablation is delayed or declined.